Recombinant multi-species IFNA21 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine IFNA21 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is a member of the alpha interferon gene cluster on the short arm of chromosome 9. Interferons are cytokines produced in response to viral infection that mediate the immune response and interfere with viral replication. The encoded protein is a type I interferon and may play a specific role in the antiviral response to rubella virus. [provided by RefSeq, Sep 2011]
The Alternative Names of target: IFN-alpha-21,IFN-alphaI,IFNA21,Interferon alpha-21,Interferon alpha-F (LeIF F),LeIF F,leIF-F
Go
to IFNA21 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-SE0981-Ag-1/ GM-Tg-hg-SE0981-Ag-2 | Human IFNA21 protein | Human |
| GM-Tg-rg-SE0981-Ag-1/ GM-Tg-rg-SE0981-Ag-2 | Rat IFNA21 protein | Rat |
| GM-Tg-mg-SE0981-Ag-1/ GM-Tg-mg-SE0981-Ag-2 | Mouse IFNA21 protein | Mouse |
| GM-Tg-cynog-SE0981-Ag-1/ GM-Tg-cynog-SE0981-Ag-2 | Cynomolgus/Rhesus macaque IFNA21 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-SE0981-Ag-1/ GM-Tg-felg-SE0981-Ag-2 | Feline IFNA21 protein | Feline |
| GM-Tg-cang-SE0981-Ag-1/ GM-Tg-cang-SE0981-Ag-2 | Canine IFNA21 protein | Canine |
| GM-Tg-bovg-SE0981-Ag-1/ GM-Tg-bovg-SE0981-Ag-2 | Bovine IFNA21 protein | Bovine |
| GM-Tg-equg-SE0981-Ag-1/ GM-Tg-equg-SE0981-Ag-2 | Equine IFNA21 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-SE0981-Ag-1/ GM-Tg-hg-SE0981-Ag-2;
GM-Tg-rg-SE0981-Ag-1/ GM-Tg-rg-SE0981-Ag-2;
GM-Tg-mg-SE0981-Ag-1/ GM-Tg-mg-SE0981-Ag-2; GM-Tg-cynog-SE0981-Ag-1/ GM-Tg-cynog-SE0981-Ag-2; GM-Tg-felg-SE0981-Ag-1/ GM-Tg-felg-SE0981-Ag-2; GM-Tg-cang-SE0981-Ag-1/ GM-Tg-cang-SE0981-Ag-2; GM-Tg-bovg-SE0981-Ag-1/ GM-Tg-bovg-SE0981-Ag-2; GM-Tg-equg-SE0981-Ag-1/ GM-Tg-equg-SE0981-Ag-2 |
| Products Name | IFNA21 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | IFNA21 |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine IFNA21 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.